A 66-kDa protein (TB66) was purified from culture filtrate (CF) and cell sonicate (CS) of Mycobacterium tuberculosis H,,Rv by immobilised metal affinity chromatography (IMAC) on a Ni-nitrilotriacetic acid (NTA) column. TB66 was found to be a fibronectinbinding protein as determined by ELISA and could be purified by affinity chromatography with fibronectin-Sepharose. A similar 66-kDa protein could be isolated also from M . bovis, M . bouis BCG, M . africanum and M . tuberculosis H,,Ra by IMAC, but not from any other mycobacteria. The NH,-terminal amino-acid sequence of TB66 from H,,Rv and M . bovis was identical and showed 85% homology with the N-terminal sequence of bovine serum albumin (BSA). A monoclonal antibody (MAb) OD4AG3 recognised a heat-stable and trypsin-sensitive epitope near the C-terminal end of TB66. This MAb also recognised the 66-kDa protein isolated from the other members of the M . tuberculosis complex. In tests of immunogenicity, TB66 elicited a delayed type hypersensitivity reaction in guinea-pigs immunised with either TB66 or with M . tuberculosis H37Rv. TB66 also elicited an antibody response in immunised guinea-pigs and stimulated murine macrophages to produce tumour necrosis factor.
Introduction
Mycobacterial diseases continue to be important causes of human morbidity and mortality. It is estimated that tuberculosis is responsible for as many as 26 YO of all avoidable adult deaths wor1dwide.l The tubercle bacillus contains several immunologically active components, most of which are widely shared among other mycobacterial species., The development of n h e l vaccines and diagnostic tests for tuberculosis requires purified and well characterised antigens that are immunologically active and species-specific. However, the complex nature and chemical diversity which characterise the antigens of pathogenic mycobacteria have limited the preparation of pure, specific and standardisable protein antigens by the classical methods of purification from culture filtrates and cell extracts.,, Secreted antigens of Mycobacterium tuberculosis may be of particular significance in the development of protective immunity. Some secreted antigens have been shown to bind fibronectin (FN).5 FN-binding antigens are prominent components of short-term Received 17 March 1994; accepted 8 June 1994.
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culture filtrates (CF) of M. tuberculosis.6 FN, a large glycoprotein commonly found in plasma and extracellular matrices, has many biological activities. It binds to various macromolecules and participates in cell-surface interactions between eukaryotic cells and micro-organism^.^ It has been demonstrated that mycobacteria bind to FN and that BCG CF inhibited attachment of organisms to FN-coated surfaces. 8 The 30/31-kDa proteins and 57-60-kDa proteins of M . tuberculosis have been shown to be FN-binding proteins.6 Mycobacteria and mycobacterial proteins are also known to be potent inducers of monocyte-derived tumour necrosis factor (TNF).', l o
We have identified a novel seroreactive 66-kDa protein (TB66) in cell sonicates (CS) and in short-term CF of M . tuberculosis." The present study was aimed at further characterising this protein to determine its role in vivo. 
Materials and methods

Preparation
Monoclonal antibodies
Murine monoclonal antibodies (MAbs) were raised in this laboratory against the soluble sonicate of M . avium complex (MAC 101). During the screening of the culture supernates obtained from the clones, one clone (OD4AG3) was found to produce a MAb that cross-reacted with H,,Rv sonicate in ELISA. On Western blotting, this MAb was found to react with an M. tuberculosis protein with an M, of c. 66 kDa.
Immobilised metal afinity chromatography (IMAC)
Proteins were purified with a nickel nitrilotriacetic acid (Ni-NTA) resin'' under non-denaturing conditions as described previously.ll Briefly, columns containing c. 1 ml of Ni-NTA resin (Qiagen, Chatsworth, CA, USA) were equilibrated with buffer A (0.5 M sodium phosphate buffer containing 0.5 M NaCI, pH 8.0). The CS and C F (in buffer A) were then loaded on to the column. The column was washed with buffer A until absorbance at 280 nm (Az8o) was 0, and bound proteins were eluted with buffer B (10 mM potassium phosphate buffer containing 0.75 M NH,Cl, pH 6.6). Samples (2 ml) were collected and those showing A280 > 0 were analysed by SDS-PAGE with acrylamide 12 YO gels (Mini-Protean I1 ready gels, BioRad) followed by Coomassie Brilliant Blue R-250 (CBB) staining. Fractions containing the 66-kDa protein (typically the first two to three samples) were pooled, dialysed and used for further studies.
Fibronectin-Sepharose chromatography
The CF of strain H,,Rv was subjected to FNSepharose chromatography. Plasma FN (Sigma) was bound to gelatin-Sepharose (Sigma) by the method of Vuento.13 CF from strain H,,Rv was then applied to the column equilibrated with 0-05 M Tris-HC1, pH 7.5, and material bound to FN was eluted with 1 M NaCl or with 2 0 m~ EDTA in Tris buffer; 2-ml fractions were collected and assayed for the presence of protein by SDS-PAGE.
Amino terminal sequencing
The 66-kDa protein obtained from C F of strain H,,Rv and M . bovis was transferred electrophoretically from an SDS-PAGE gel to polyvinylidine difluoride membranes (0.2 pm, BioRad) with the Transblot apparatus at a constant current of 270 mA for 90 min. The transfers were stained for 1 min in Coomassie Blue, destained briefly in methanol 40 YO and acetic acid 10% in water, washed in distilled water, and air-dried. Protein was cut from the membrane and amino terminal sequencing was performed by Dr J. Pohl, Emory University, Atlanta, GA, USA. Searches of the Gen Bank (release 72.0) and SWISS-PROT (release 22.0) databases were conducted by FASTA software to determine sequence homology.
Western blotting
The 66-kDa proteins obtained by IMAC were subjected to SDS-PAGE 12 YO and transferred electrophoretically from the gel to nitrocellulose membranes (0.2 pm pore size, BioRad) by the method of Towbin et all4 with a Trans-blot apparatus (BioRad) and LKB 2002 Power supply. MAb OD4AG3 was used as the primary antibody. Peroxidase conjugated rabbit antimouse polyvalent immunoglobulin (BioRad) diluted 1 in 1000 was used as the secondary antibody. The reaction was visualised with 4-chloro-1 -naphthol and H,O, as the substrate, and was stopped by washing the membrane in distilled water.
Dot immunobinding assay
The assay was performed as described previo~s1y.l~ Briefly, TB66 obtained from strain H,,Rv CF and CS was spotted on nitrocellulose and air-dried. The subsequent immunoassay was performed as described above. MAb OD4AG3 was used as the primary antibody and the effect of trypsin and carboxypeptidase on the reactivity of TB66 was determined by incubating the protein with each enzyme before assessment of its immunoreactivity.
Detection of FN-binding property of TB66
The ability of TB66 to bind FN was determined in two ways by ELISA. (1) TB66 (1 pglwell) was added to wells of a microtitration plate (Falcon, BectonDickinson Labware, NJ, USA) coated with FN (1 pg/well). Bound protein was detected by MAb OD4AG3. (2) F N was added to wells coated with TB66 (1 pg/well) and bound F N was detected with affinity purified rabbit anti-FN polyclonal antibody (Sigma). Controls included TB66 added to bovine serum albumin (BSA)-coated wells and FN-coated wells without TB66. The reaction was visualised with the appropriate peroxidase conjugated secondary antibody, and o-phenylene diamine dihydrochloride and H,O, as the substrate. The extinction was measured in a Titertek Multiskan reader at 492 nm.
DTH reaction
Three groups, each consisting of three male Hartley strain guinea-pigs weighing 400 g each, were used for the study. Each animal from groups I and I1 was given two subcutaneous injections, 3 weeks apart, of H,,Rv sonicate containing 1 mg of protein and 200 pg TB66 (from H,,Rv CF), respectively, in incomplete Freund's adjuvant (IFA). Animals in group I11 formed the control group and were given IFA only. Three weeks after the second injection, all the animals were tested with 0-1-ml intradermal injections of H,,Rv sonicate (5 pg), TB66 of H,,Rv (1 and 5 pg) and PPD. PPD ( 5 tuberculin units corresponding to protein 0.4 pg/O-1 ml) was kindly provided by Dr J. Crawford (CDC, Atlanta, USA). The reactions (diameter of erythema and induration) were read at 18,24,48 and 72 h. The animals were bled by cardiac puncture after 72 h and the serum from each animal was tested by ELISA for the presence of antibodies to TB66. Subsequently, sera from each group were pooled and the antibody titre was determined. The titre was defined as the last serum dilution that gave a positive reaction with TB66.
TNF assay
Supernates containing T N F activity were generated by adding TB66 to 16-mm diameter tissue-culture wells (Falcon) containing 1 0' mouse macrophages of 5774 (American Type Culture Collection [ATCC], Rockville, MD, USA) in 1 ml of RPMI 1640 medium supplemented with 2 mM L-glutamine, penicillin 100 units/ml and streptomycin 100 pg/ml. The macrophages were incubated with TB66 (5 pg) at 37°C in air with CO, 5 % and harvested at 22-24 h. Control wells contained macrophages incubated without TB66. In some wells, TNF activity was generated by stimulation of macrophages with bacterial LPS (10 pg, Sigma). TB66 was also pre-incubated for 1 h at 37°C with MAb OD4AG3 before addition to macrophages, to determine whether this MAb neutralised TB66 and prevented it from stimulating the macrophages. As a control, MAb OD4AF1 (which does not recognise TB66) was also pre-incubated with TB66 and then added to the macrophages. The supernates were collected after sedimentation of the cells and were stored at -20°C until the time of assay. TNF activity was assessed by cytotoxicity for murine L-929 fibroblasts (ATCC) by the method described by Flick and Gifford" with some modifications. Supernates from experimental and control wells were added to confluent monolayers of L-929 fibroblasts obtained by incubation of cells at a density of 2.5 x lo4 cells/ 0.1 ml/well (flat-bottomed tissue culture treated plates; Corning, NY, USA) in fetal bovine serum 20% and modified Eagle's medium for 24-48 h at 37°C. Actinomycin D (1 pg/ml) was added to each well and the cells were incubated for 20 h at 37°C. Cell lysis was determined by staining viable cells with 50 pl of neutral red dye (0.1 % w/v) in phosphate-buffered saline (PBS) for 1 h at 37°C. The stained cells were washed with PBS and lysed with ethanol 50Y0-0.1 M monobasic sodium phosphate. Absorbance of neutral red was measured at 570 nm with a Titertek Multiskan reader. Measurements were the mean of eight replicates. The cytotoxicity of TB66 towards the fibroblasts, if any, was determined by incubating the protein with the fibroblasts and performing the assay as above. Cytotoxicity was defined as a reduction in the neutral red uptake by the fibroblasts which was observed as a decrease in absorbance of neutral red.
Results
Purijication of TB66
Ni-NTA chromatography. M A C of CS and C F of strains H,,Rv, H,,Ra, M . bovis, BCG and M . africanum yielded fractions that contained predominantly a protein with an M, of 66 kDa. Fig. 1 a+ shows the Ni-NTA eluates obtained from the C F of these organisms. No binding to Ni-NTA was observed with any other mycobacterial CS or C F tested. Sterile 7H9 broth showed no binding to Ni-NTA.
FN-Sepharose chromatography. The experimental conditions used allowed the binding of F N to gelatinSepharose for subsequent use in the isolation of FNbinding proteins. C F of strain H,,Rv bound to FNSepharose and the bound material could be eluted with NaCl as well as EDTA. The eluates showed the presence of a 66-kDa protein by SDS-PAGE ( fig. 1 f  and g ). C F did not bind to gelatin-Sepharose which was not coupled to FN. Also, NaCl or EDTA did not wash away the F N that was bound to the gelatinSepharose column.
Characterisation of TB66
The N-terminal amino-acid sequence of TB66 (from GS and CF) from strain H,,Rv and from M . bovis was found to be identical. The sequence was determined to be (OD,,, c. 0.6). Also, TB66 bound to FN-coated wells could be detected with MAb OD4AG3 (OD,,, c. 0.7). observed in the dot immunobinding assay with MAb OD4AG3 when TB66 was incubated with trypsin ( fig.  3) . Treatment of TB66 with a mixture of carb-
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Immunoreactiuity of TB66
oxypeptidases A and B for 15 min produced a protein of c. 60kDa which was not recognised by MAb TB66 obtained by IMAC of all the members of M . tuberculosis complex showed a very strong reaction with MAb OD4AG3 in immunoblotting ( fig. 2a-e) . TB66 obtained by FN-Sepharose chromatography of strain H,,Rv C F also showed the presence of
The results are summarised in the table as the OD4AG3 reactivity ( fig. 2f and g ). No reaction was average diameter of erythema observed in all animals OD4AG3 in the dot immunobinding assay ( fig. 3) . 
DTH reaction
Discussion
There is considerable interest in the identification of immunodominant and potentially protective protein antigens of M . tuberculosis because of the current increase in tuberculosis world wide. Earlier, we reported the isolation of a 66-kDa protein (TB66) from M . tuberculosis in a single step by IMAC.ll This seroreactive protein was found to be distinct from the well-characterised immunodominant proteins of M . tuberculosis. A heat-stable and protein epitope of this protein was recognised by MAb OD4AG3 raised in this laboratory. OD4AG3-reactivity was abolished in the 60-kDa protein which was produced after carboxypeptidase treatment of TB66, suggesting that the epitope lies within a 60 amino acid region at the Cterminal end of TB66. No such protein could be isolated from mycobacteria other than the members of the M . tuberculosis complex. Even MAC 10 1, against which MAb OD4AG3 was raised, did not bind to Ni-NTA, suggesting that MAC10 l possess an OD4AG3-reactive protein distinct from TB66, which thus appears to be an M . tuberculosis-complex-specific protein.
TB66 was found to bind FN and could be purified by FN-Sepharose chromatography. Neither the salt nor the EDTA eluates obtained by FN-Sepharose chromatography contained the well-known FN-binding antigens of M . tuberculosis-Le., the 30-32-kDa or the 57-60-kDa proteins.6 It is possible that, under the conditions used here for chromatography, these proteins do not bind to FN, or are bound to FNSepharose but could not be eluted with NaCl or EDTA. Abou-Zeid et aL6 have reported their unsuccessful attempt to isolate the FN-binding antigens by FN-Sepharose, because of the strong binding of these antigens to FN. MAb OD4AG3 was found to bind strongly the synthetic 37 amino acid FN-binding peptide D3 (Sigma)', in ELISA (OD,,, c. 0.6) . Binding of MAb OD4AG3 did not inhibit the FN-binding capacity of D3 or TB66, suggesting that the epitope recognised by this antibody is not involved in the FNbinding function. The OD4AG3-binding region of peptide D3 probably lies within the Nl-N20 region of D3 because the FN-binding site has been shown to be within the 21-33 amino acid region.', Mycobacterial preparations such as CF, PPD and antigen 5 are known to stimulate monocytes and alveolar macrophages to produce TNF.' C F proteins of 150,92,60,58,46 and 20 kDa have been reported to have TNF stimulating activity.l0.ls This is the first report that a 66-kDa protein of M . tuberculosis stimulates TNF production by macrophages in vitro. It remains to be determined whether, and how, TNF may be relevant to the immunopathogenesis of tuberculosis. The direct stimulatory effects of mycobacterial constituents may provide the basis for the apparent restricted specificity of suppression by monocytes in tuberculosis.
TB66 at a 1-pg concentration produced DTH reactions in TB66-and H,,Rv-sensitised guinea-pigs.
